《大行報告》瑞信上調比亞迪電子(00285.HK)目標價至10.2元 評級「跑輸大市」
瑞信發表報告指,比亞迪電子(00285.HK)指引今年純利將錄得雙位數增長,相對原先的80%增長目標,「雙位數」範圍較大,相信最終增長幅度將視乎肺炎疫情的影響程度。
該行降比亞迪電子今明兩年收入預測分別13%及18%,上調今年盈測3%,明年則下調12%,以反映收入下降、毛利率改善、營運成本提升、低稅率及更多非營運收入等因素。目標價自10.1元調整至10.2元,評級維持「跑輸大市」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.